TRPC6 and diabetes mellitus: GLP-1 agonists, such as liraglutide, reduce the expression of glomerular TRPC6 in STZ-induced diabetes in Sprague Dawley rats and may act to reduce interactions between TRPC6 and NADPH oxidases [87].